1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Continuous Blood Purification System Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Continuous Blood Purification System by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Continuous Blood Purification System by Country/Region, 2018, 2022 & 2029
2.2 Continuous Blood Purification System Segment by Type
2.2.1 Hemodialysis System
2.2.2 Hemofiltration System
2.2.3 Continuous Arteriovenous Hemofiltration System
2.2.4 Hemoperfusion System
2.2.5 Peritoneal Dialysis System
2.2.6 Others
2.3 Continuous Blood Purification System Sales by Type
2.3.1 Global Continuous Blood Purification System Sales Market Share by Type (2018-2023)
2.3.2 Global Continuous Blood Purification System Revenue and Market Share by Type (2018-2023)
2.3.3 Global Continuous Blood Purification System Sale Price by Type (2018-2023)
2.4 Continuous Blood Purification System Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Continuous Blood Purification System Sales by Application
2.5.1 Global Continuous Blood Purification System Sale Market Share by Application (2018-2023)
2.5.2 Global Continuous Blood Purification System Revenue and Market Share by Application (2018-2023)
2.5.3 Global Continuous Blood Purification System Sale Price by Application (2018-2023)
3 Global Continuous Blood Purification System by Company
3.1 Global Continuous Blood Purification System Breakdown Data by Company
3.1.1 Global Continuous Blood Purification System Annual Sales by Company (2018-2023)
3.1.2 Global Continuous Blood Purification System Sales Market Share by Company (2018-2023)
3.2 Global Continuous Blood Purification System Annual Revenue by Company (2018-2023)
3.2.1 Global Continuous Blood Purification System Revenue by Company (2018-2023)
3.2.2 Global Continuous Blood Purification System Revenue Market Share by Company (2018-2023)
3.3 Global Continuous Blood Purification System Sale Price by Company
3.4 Key Manufacturers Continuous Blood Purification System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Continuous Blood Purification System Product Location Distribution
3.4.2 Players Continuous Blood Purification System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Continuous Blood Purification System by Geographic Region
4.1 World Historic Continuous Blood Purification System Market Size by Geographic Region (2018-2023)
4.1.1 Global Continuous Blood Purification System Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Continuous Blood Purification System Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Continuous Blood Purification System Market Size by Country/Region (2018-2023)
4.2.1 Global Continuous Blood Purification System Annual Sales by Country/Region (2018-2023)
4.2.2 Global Continuous Blood Purification System Annual Revenue by Country/Region (2018-2023)
4.3 Americas Continuous Blood Purification System Sales Growth
4.4 APAC Continuous Blood Purification System Sales Growth
4.5 Europe Continuous Blood Purification System Sales Growth
4.6 Middle East & Africa Continuous Blood Purification System Sales Growth
5 Americas
5.1 Americas Continuous Blood Purification System Sales by Country
5.1.1 Americas Continuous Blood Purification System Sales by Country (2018-2023)
5.1.2 Americas Continuous Blood Purification System Revenue by Country (2018-2023)
5.2 Americas Continuous Blood Purification System Sales by Type
5.3 Americas Continuous Blood Purification System Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Continuous Blood Purification System Sales by Region
6.1.1 APAC Continuous Blood Purification System Sales by Region (2018-2023)
6.1.2 APAC Continuous Blood Purification System Revenue by Region (2018-2023)
6.2 APAC Continuous Blood Purification System Sales by Type
6.3 APAC Continuous Blood Purification System Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Continuous Blood Purification System by Country
7.1.1 Europe Continuous Blood Purification System Sales by Country (2018-2023)
7.1.2 Europe Continuous Blood Purification System Revenue by Country (2018-2023)
7.2 Europe Continuous Blood Purification System Sales by Type
7.3 Europe Continuous Blood Purification System Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Continuous Blood Purification System by Country
8.1.1 Middle East & Africa Continuous Blood Purification System Sales by Country (2018-2023)
8.1.2 Middle East & Africa Continuous Blood Purification System Revenue by Country (2018-2023)
8.2 Middle East & Africa Continuous Blood Purification System Sales by Type
8.3 Middle East & Africa Continuous Blood Purification System Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Continuous Blood Purification System
10.3 Manufacturing Process Analysis of Continuous Blood Purification System
10.4 Industry Chain Structure of Continuous Blood Purification System
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Continuous Blood Purification System Distributors
11.3 Continuous Blood Purification System Customer
12 World Forecast Review for Continuous Blood Purification System by Geographic Region
12.1 Global Continuous Blood Purification System Market Size Forecast by Region
12.1.1 Global Continuous Blood Purification System Forecast by Region (2024-2029)
12.1.2 Global Continuous Blood Purification System Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Continuous Blood Purification System Forecast by Type
12.7 Global Continuous Blood Purification System Forecast by Application
13 Key Players Analysis
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Continuous Blood Purification System Product Portfolios and Specifications
13.1.3 Baxter Continuous Blood Purification System Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 Fresenius Medical Care
13.2.1 Fresenius Medical Care Company Information
13.2.2 Fresenius Medical Care Continuous Blood Purification System Product Portfolios and Specifications
13.2.3 Fresenius Medical Care Continuous Blood Purification System Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Fresenius Medical Care Main Business Overview
13.2.5 Fresenius Medical Care Latest Developments
13.3 Nikkiso Medical
13.3.1 Nikkiso Medical Company Information
13.3.2 Nikkiso Medical Continuous Blood Purification System Product Portfolios and Specifications
13.3.3 Nikkiso Medical Continuous Blood Purification System Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Nikkiso Medical Main Business Overview
13.3.5 Nikkiso Medical Latest Developments
13.4 B. Braun
13.4.1 B. Braun Company Information
13.4.2 B. Braun Continuous Blood Purification System Product Portfolios and Specifications
13.4.3 B. Braun Continuous Blood Purification System Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 B. Braun Main Business Overview
13.4.5 B. Braun Latest Developments
13.5 Nxstage Medical
13.5.1 Nxstage Medical Company Information
13.5.2 Nxstage Medical Continuous Blood Purification System Product Portfolios and Specifications
13.5.3 Nxstage Medical Continuous Blood Purification System Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Nxstage Medical Main Business Overview
13.5.5 Nxstage Medical Latest Developments
13.6 Asahi Kasei Medical
13.6.1 Asahi Kasei Medical Company Information
13.6.2 Asahi Kasei Medical Continuous Blood Purification System Product Portfolios and Specifications
13.6.3 Asahi Kasei Medical Continuous Blood Purification System Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Asahi Kasei Medical Main Business Overview
13.6.5 Asahi Kasei Medical Latest Developments
13.7 Medtronic
13.7.1 Medtronic Company Information
13.7.2 Medtronic Continuous Blood Purification System Product Portfolios and Specifications
13.7.3 Medtronic Continuous Blood Purification System Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Medtronic Main Business Overview
13.7.5 Medtronic Latest Developments
13.8 Toray Medical
13.8.1 Toray Medical Company Information
13.8.2 Toray Medical Continuous Blood Purification System Product Portfolios and Specifications
13.8.3 Toray Medical Continuous Blood Purification System Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Toray Medical Main Business Overview
13.8.5 Toray Medical Latest Developments
13.9 Infomed
13.9.1 Infomed Company Information
13.9.2 Infomed Continuous Blood Purification System Product Portfolios and Specifications
13.9.3 Infomed Continuous Blood Purification System Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Infomed Main Business Overview
13.9.5 Infomed Latest Developments
13.10 Medical Components
13.10.1 Medical Components Company Information
13.10.2 Medical Components Continuous Blood Purification System Product Portfolios and Specifications
13.10.3 Medical Components Continuous Blood Purification System Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Medical Components Main Business Overview
13.10.5 Medical Components Latest Developments
13.11 Medites Pharma Spol
13.11.1 Medites Pharma Spol Company Information
13.11.2 Medites Pharma Spol Continuous Blood Purification System Product Portfolios and Specifications
13.11.3 Medites Pharma Spol Continuous Blood Purification System Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Medites Pharma Spol Main Business Overview
13.11.5 Medites Pharma Spol Latest Developments
13.12 SWS Medical
13.12.1 SWS Medical Company Information
13.12.2 SWS Medical Continuous Blood Purification System Product Portfolios and Specifications
13.12.3 SWS Medical Continuous Blood Purification System Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 SWS Medical Main Business Overview
13.12.5 SWS Medical Latest Developments
13.13 Ningbo Tianyi Medical Appliance
13.13.1 Ningbo Tianyi Medical Appliance Company Information
13.13.2 Ningbo Tianyi Medical Appliance Continuous Blood Purification System Product Portfolios and Specifications
13.13.3 Ningbo Tianyi Medical Appliance Continuous Blood Purification System Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Ningbo Tianyi Medical Appliance Main Business Overview
13.13.5 Ningbo Tianyi Medical Appliance Latest Developments
13.14 Jafron Biomedical
13.14.1 Jafron Biomedical Company Information
13.14.2 Jafron Biomedical Continuous Blood Purification System Product Portfolios and Specifications
13.14.3 Jafron Biomedical Continuous Blood Purification System Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Jafron Biomedical Main Business Overview
13.14.5 Jafron Biomedical Latest Developments
14 Research Findings and Conclusion
| ※参考情報 持続的血液浄化装置は、重篤な病状にある患者に対して重要な治療手段の一つとして、血液中の有害物質や老廃物を除去するための医療機器です。特に、腎機能が低下した患者や、急性腎不全、敗血症、多臓器不全などの状態にある患者に対する治療として用いられます。 この装置の定義は、血液を連続的に浄化し、不必要な物質や毒素を取り除くことで、患者の生理的バランスを保つための医療機器とされます。持続的血液浄化は、従来の透析と異なり、より長時間にわたり血液循環を行うことが特徴です。これにより、短期間での施術に伴う身体への負担を軽減し、持続的に患者の状態を監視することが可能となります。 特徴としては、まず第一に連続性が挙げられます。持続的に行われるため、患者にとって体への負担が少なく、ストレスのかかるダイアルシスセッションを避けることができるという利点があります。また、浄化過程で使用するフィルターや膜の技術が向上しているため、より効率的に有害物質を除去することができるようになっています。 種類には、主に以下のようなものがあります。第一に、持続的静脈-静脈血液浄化（CVVH）、持続的静脈-動脈血液浄化（CVVHD）、持続的静脈-動脈透析（CVVHDF）という3つの処理方式があります。CVVHは血液中の分子を物理的に除去する方法、CVVHDは拡散原理を利用した手法、CVVHDFはその二つの方式を併用したハイブリッドなやり方です。 用途としては、主に急性腎不全の患者や、敗血症、肝不全など、体内に毒素が蓄積している病態に対して用いられます。慢性腎不全や腎移植の合併症に対しても、補助的な治療として使用されることがあります。また、近年では、がん治療に伴う体内の老廃物の除去にも応用が試みられています。 関連技術としては、膜技術や透析技術が有名ですが、最近では生体適合性材料の開発や、自己調整型のフィルター技術なども進展しています。これにより、より効果的で安全な血液浄化が期待されています。また、AIを活用したモニタリングシステムの導入により、患者の状態をリアルタイムで把握し、最適な浄化が行えるようになることが期待されています。 持続的血液浄化装置の利点は、患者の生活の質を向上させることにあります。従来の透析治療に比べて、体への負担が少なく、治療の柔軟性が高いため、患者が生活の質を保ちながら治療を受けることが可能になります。医療現場でも、患者の状態に応じた個別化された治療が進んでおり、持続的血液浄化装置はその一翼を担っています。 今後の展望としては、持続的血液浄化装置の技術革新が挙げられます。新たな材料や技術の開発により、より安全で効果的な装置が実用化されることで、より多くの患者に恩恵をもたらすことが期待されます。また、遠隔医療の発展により、医療従事者が患者をより適切にサポートできる環境が整いつつあり、その中で持続的血液浄化装置の役割がさらに重要になるでしょう。これによって、緊急治療が必要な患者に対する迅速かつ適切な対応が可能となり、更なる生命の救助が実現されることを願っています。 持続的血液浄化装置は、急性の病態に対する優れた治療法として、その必要性が高まっています。病気の深刻さや進行に応じて適切に使用されることで、多くの患者がより良い結果を得ることができ、医療技術の進歩によって期待される未来に向けた道が開かれることを期待しています。 |
